Rekord LOINC: 85042-0
Tylko wersja angielska ACTIVE
Szczegóły rekordu LOINC
Informacje podstawowe
| Kod LOINC: |
85042-0
FHIR
|
| Long Common Name: | Staphylococcus aureus glycopeptide resistant identified [Type] in Isolate |
| Short Name: | SA glyco resist Islt |
| Status: | ACTIVE |
| Class Type: | 1 |
Fully Specified Name (FSN)
EN
Oryginalna wersja angielska
Staphylococcus aureus.glycopeptide resistant identified
:
Type
:
Pt
:
Isolate
:
Nom
:
-
Klasyfikacja
| Class: |
ENMICRO
|
| Consumer Name: | - |
| Order/Observation: | Observation |
| Panel Type: | - |
Informacje dodatkowe
| Units Required: | - |
| Example Units: | - |
| UCUM Units: | - |
| Version Last Changed: | 2.58 |
Definicja i opis
EN
This term is used to report the presence of Staph aureus strains with intermediate or heterogeneous glycopeptide resistance, called GISA and hGISA respectively. One method for differentiating GISA from hGISA is based on comparison of inhibitory concentration results for vancomycin plus teicoplanin [LOINC: 85045-3] with the result for vancomycin alone [LOINC: 7059-9]. This term was created for, but is not limited in use to, bioMerieux's ETEST GRD assay, which, when used together with a vancomycin susceptibility gradient strip, can differentiate between GISA and hGISA.
Powiązane nazwy
ID; Infectious Disease; InfectiousDisease; Islt; Isol; Isolated; Microbiology; Nominal; o71; Point in time; Random; S aureus; SA glyco resist; Staph; Typ